Summary
This Israeli company has developed innovative and revolutionary wound healing and closure solutions.
The technology allows for combined skin stretching and enhanced wound healing by a novel oxygen-enriched and irrigation-assisted vacuum device for early and immediate wound closure. The company is seeking partners under a distribution service agreement.
Description
This Israeli medical device company specializes in research, design, and development of cutting-edge wound healing and closure technologies. The company developed innovative devices and technologies that accelerate wound healing and closure. It was established in 2010 and as of today its
staff includes 6 employees.
The company developed its product after identifying the need for improving the current method of wound closure, which has limitations such as long recovery time and substantial risk of infection. The device uniquely applies a tension relief mechanism,
intended for the management of simple and complex wounds for civil, military, and mass-casualty injury applications.
The device distributes the stress on the skin away from the wound edges so that tension on the scar can be substantially reduced, thus enabling the closure of extremely hard-to-close, high-tension wounds and
improving the quality, functionality, and aesthetics of the healed wound. Through its ability to effectively stretch the skin, it reduces the need for skin grafts and flaps.
With the purpose of promoting wound healing while minimizing the risk of bleeding, the company also developed a cutting-edge, non-pharmaceutical wound healing device that applies regulated oxygen-enriched and irrigation negative pressure-assisted wound treatment (ROI-NPT) for enhancing the healing of infected, complex, and hard-to-heal wounds.
For better detection and bleeding control, the device is equipped with specially designed user-friendly software,
electronics, and alarms.
The company portfolio also includes an advanced hospital and home-use portable ROI-NPT device, improving patient ambulation and expanding its treatment arena to the growing field of home care wound therapy, including rural and low-resource settings.
The company operates under ISO 13485. The devices are FDA and CFDA approved. They are in the final stage of CE certificate renewal. The company's products were granted patents in the US, Canada, Europe, and other countries.
The company is already active overseas and exports to countries including China, Hong Kong, Kenya, and Panama.
The company wishes to expand its international activity and is therefore looking for distributors in the field of medical devices that specialize in similar products and technologies. Distributors' role would be to help the company reach its end customers: hospitals and doctors.